Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Kim Peter Sung-JipSVP & GM Industrial Business | Option exercise | M | — 5,488 sh | Feb 4, 2026 |
| 9 | Shaikh KashifDirector, President and CEO | Grant or award | A | — 238.2K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Swain JunkoSVP, Chief Accounting Officer | Tax withholding | F | $47K 650 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 9 | Shaikh KashifDirector, President and CEO | Grant or award | A | — 238.2K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Go WilliamChief Medical Officer | Grant or award | A | — 154.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Go WilliamChief Medical Officer | Grant or award | A | — 44.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Kleczynski Robert ASVP, Controller & Tax | Option exercise | M | — 1,474 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Jones Jeanne MEVP, CFO, Audit & Risk | Grant or award | A | — 18.8K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Kleczynski Robert ASVP, Controller & Tax | Option exercise | M | — 7,019 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Peterson Timothy GeorgeEVP Chf Cust & Tech Officer | Grant or award | A | — 11.3K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Ghingo John FDirector, President | Grant or award | A | — 201.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Conway Kevin JohnChief Financial Officer | Tax withholding | F | $406 72 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Honorable Colette DEVP CLO Compliance & Corp Sec | Grant or award | A | — 12.8K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Bohen SeanDirector, PRESIDENT AND CEO | Grant or award | A | — 850.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Kleczynski Robert ASVP, Controller & Tax | Option exercise | M | — 2,110 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Stiles Spencer SPresident and COO | Option exercise | M | — 13.8K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 9 | Cowan ChadChief Scientific Officer | Grant or award | A | — 135.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Perkins Tandra CDirector | Grant or award | A | $1,125 14 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Dixon Jonathan V.GENERAL COUNSEL | Grant or award | A | — 26.1K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Jones Jeanne MEVP, CFO, Audit & Risk | Option exercise | M | — 24.7K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Bohen SeanDirector, PRESIDENT AND CEO | Grant or award | A | — 275.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Howze YalondaINTERIM CEO & PRESIDENT | Option exercise | M | — 1,673 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Davie Colin M.Pres. & GM, Glob. Supply Chain | Option exercise | M | — 2,976 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Kleczynski Robert ASVP, Controller & Tax | Option exercise | M | — 1,684 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Koetje Todd MSee Remarks. | Tax withholding | F | $14K 156 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Kleczynski Robert ASVP, Controller & Tax | Option exercise | M | — 1,684 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Torres Isaac P.Director | Grant or award | A | $14K 212 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 8 | Okupe OluyemiChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $139K 5,262 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 8 | Allaire JeremyDirector, Chairman and CEO | Tax withholding | F | $537K 8,404 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Novack Jeffrey AdamSecretary and General Counsel | Tax withholding | F | $61K 2,970 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Fox-Geen JeremyChief Financial Officer | Tax withholding | F | $248K 3,877 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Bachrodt AmySVP, Finance | Open-market sale · 10b5-1 plan | SELL | $8,830 200 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Gummadi SuryaPresident - Americas | Open-market sale · 10b5-1 plan | SELL | $144K 1,728 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Novack Jeffrey AdamSecretary and General Counsel | Tax withholding | F | $51K 2,492 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 6 | Feierstein Matthew DavidPresident | Open-market sale · 10b5-1 plan | SELL | $8,388 720 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 6 | Allaire JeremyDirector, Chairman and CEO | Option exercise | M | — 2,434 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 6 | Feierstein Matthew DavidPresident | Open-market sale · 10b5-1 plan | SELL | $108K 10.0K sh | Feb 4, 2026 traded Feb 4, 2026 |
| 6 | Remer Eric RichardDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $159K 14.7K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 5 | Bharucha DavidChief Medical Officer | Grant or award | A | — 136.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Zojwalla NaseemCHIEF MEDICAL OFFICER | Grant or award | A | — 106.3K sh | Feb 4, 2026 traded Feb 2, 2026 |